Version 2.1 now available: Clinician FAQs and guidance on COVID-19 vaccine for patients receiving SACT – Version 2.1
An updated version of Clinician FAQs and guidance on COVID-19 vaccine for patients receiving SACT is now available here.
Updates include:
Updated Allergy advice
Moderna Vaccine reference
Revised recommendation for CDK4/6 inhibitors
Bladder instillation added
Introduction – suggestion for patients awaiting to start SACT
Introduction – points rearranged
FAQ 1 – amended wording for monoclonal antibodies
References to “When blood counts have maximally recovered (towards end of cycle)” and “(providing FBC is within normal/acceptable range)” removed
T-VEC, Radiotherapy, Chemo-Radiotherapy added to table
Immunomodulatory (iMiDs) – suggested timings changed
Updated to reflect option to give both dose of vaccine prior to starting SACT if timing allows.
